[HTML][HTML] Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis

RB Mrid, N Bouchmaa, H Ainani, R El Fatimy… - Biomedicine & …, 2022 - Elsevier
Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic autoimmune
disorder affects the lining of synovial joints in about 0.5% of people and may induce severe …

Mesenchymal stem cell-based therapy for rheumatoid arthritis

M Sarsenova, A Issabekova, S Abisheva… - International journal of …, 2021 - mdpi.com
Mesenchymal stem cells (MSCs) have great potential to differentiate into various types of
cells, including but not limited to, adipocytes, chondrocytes and osteoblasts. In addition to …

Cell-based therapies for rheumatoid arthritis: opportunities and challenges

YJ Li, Z Chen - Therapeutic advances in musculoskeletal …, 2022 - journals.sagepub.com
Rheumatoid arthritis (RA) is the most common immune-mediated inflammatory disease
characterized by chronic synovitis that hardly resolves spontaneously. The current treatment …

Adipose-derived stem cell exosomes as a novel anti-inflammatory agent and the current therapeutic targets for rheumatoid arthritis

TH Chang, CS Wu, SH Chiou, CH Chang, HJ Liao - Biomedicines, 2022 - mdpi.com
Patients with rheumatoid arthritis (RA), a chronic inflammatory joint disorder, may not
respond adequately to current RA treatments. Mesenchymal stem cells (MSCs) elicit several …

Inflammation‐Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation

MJ Shin, JY Park, JY Park, SH Lim, H Lim… - Advanced …, 2024 - Wiley Online Library
Current clinical therapeutic efficacy for the treatment of osteo‐and rheumatoid‐arthritis is
obviously limited. Although mesenchymal stem cells (MSCs) are considered as a source of …

The effect of acknowledged and novel anti-rheumatic therapies on periodontal tissues—a narrative review

MA Martu, GA Maftei, I Luchian, OM Stefanescu… - Pharmaceuticals, 2021 - mdpi.com
Rheumatoid arthritis (RA) and periodontal disease (PD) are chronic complex inflammatory
diseases with several common susceptibility factors, especially genetic and environmental …

Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone-and joint-associated musculoskeletal disorders: a new frontier

MH Gerami, R Khorram, S Rasoolzadegan… - European Journal of …, 2023 - Springer
Exosomes are membranous vesicles with a 30 to 150 nm diameter secreted by
mesenchymal stem/stromal cells (MSCs) and other cells, such as immune cells and cancer …

MSCs Deliver Hypoxia‐Treated Mitochondria Reprogramming Acinar Metabolism to Alleviate Severe Acute Pancreatitis Injury

Z Hu, D Wang, J Gong, Y Li, Z Ma, T Luo… - Advanced …, 2023 - Wiley Online Library
Mitochondrial function impairment due to abnormal opening of the mitochondrial
permeability transition pore (MPTP) is considered the central event in acute pancreatitis; …

Reestablish immune tolerance in rheumatoid arthritis

Z Shuai, S Zheng, K Wang, J Wang… - Frontiers in …, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease. Despite the wide
use of conventional synthetic, targeted and biologic disease modifying anti-rheumatic drugs …

Therapeutic effects of columbianadin from Angelicae Pubescentis radix on the progression of collagen-induced rheumatoid arthritis by regulating inflammation and …

S Chen, Y Wang, L Zhang, Y Han, C Liang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Angelicae pubescentis radix (APR) has a long history in
the treatment of rheumatoid arthritis (RA) in China. It has the effects of dispelling wind to …